Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Clasificación en acciones #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Precio por acción
$0.1559364
Última sincronización: 2026-09-18
Capitalización bursátil
$195.17K
Cambio (1 día)
6.60%
Cambio (1 año)
-30.91%
País
GB
Comercio Fusion Antibodies plc (FAB)

Categoría

Historial de desdoblamientos de acciones de Fusion Antibodies plc (FAB)
La acción Fusion Antibodies plc (símbolo: FAB) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Sep 20, 2026.
Una acción FAB comprada antes de Sep 20, 2026 equivaldría hoy a 0 acciones FAB.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH